Effects of doxofylline as an adjuvant on severe exacerbation and long‐term prognosis for COPD with different clinical subtypes

OBJECTIVE: This study aimed to investigate the effectiveness of doxofylline as an adjuvant in reducing severe exacerbation for different clinical subtypes of chronic obstructive pulmonary disease (COPD). METHODS: The clinical trial was an open‐label non‐randomized clinical trial that enrolled patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mei‐Feng, He, Wei, Huang, De‐Sheng, Jia, Hui, Zhong, Zhao‐Shuang, Li, Nan, Li, Shan‐Shan, Xia, Shu‐Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500324/
https://www.ncbi.nlm.nih.gov/pubmed/37562435
http://dx.doi.org/10.1111/crj.13670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500324/
https://www.ncbi.nlm.nih.gov/pubmed/37562435
http://dx.doi.org/10.1111/crj.13670

Ejemplares similares